Search

  • HOME
  • Search
Original Articles
Clinical Efficacy of Belotecan (CKD-602), Newly Developed Camptothecin Analog, in the 2nd Line Treatment of Relapsed Small Cell Lung Cancer.
Hee Jung Ban, In Jae Oh, Kyu Sik Kim, Jin Yung Ju, Yong Soo Kwon, Yu Il Kim, Sung Chul Lim, Young Chul Kim
Tuberc Respir Dis. 2009;66(2):93-97.   Published online February 1, 2009
PDFPDF    
The Clinical Characteristics and Outcomes of Short-term Treatment in Patients with Recurrent Pulmonary Tuberculosis.
Seung Soo Yoo, Jee Suk Kwon, Yeh Rim Kang, Jeong Woo Lee, Seung Ick Cha, Jae Yong Park, Tae Hoon Jung, Chang Ho Kim
Tuberc Respir Dis. 2008;64(5):341-346.   Published online May 1, 2008
PDFPDF    
Clinical Manifestations of Persistent Smear Positive and Culture Negative Sputum Tests 5 Months after First-line Anti-Tuberculous Chemotherapy.
Do Hyung Kim, Su Hee Hwang, Du Su Cheon, Jin Hong Min, Hyung Seok Kang, Seung Gyu Park
Tuberc Respir Dis. 2007;63(5):417-422.   Published online November 1, 2007
PDFPDF    
Prognosis of Patients with Non-Small Cell Lung Cancer after Surgery.
Min Jong Kang, Gye Young Park, Chul Gyu Yoo, Hee Soon Chung, Young Whan Kim, Sung Koo Han, Young Soo Shim
Tuberc Respir Dis. 1996;43(3):331-338.   Published online June 1, 1996
PDFPDF    

Tuberculosis and
Respiratory Diseases

Print ISSN: 1738-3536
Online ISSN: 2005-6184



ABOUT
ARTICLE & TOPICS
Article category

Browse all articles >

Topics

Browse all articles >

BROWSE ARTICLES
FOR CONTRIBUTORS
Editorial Office
101-605, 58, Banpo-daero, Seocho-gu (Seocho-dong, Seocho Art-Xi), Seoul 06652, Korea
Tel: +82-2-575-3825, +82-2-576-5347    Fax: +82-2-572-6683    E-mail: katrdsubmit@lungkorea.org                

Copyright © 2024 by The Korean Academy of Tuberculosis and Respiratory Diseases. All rights reserved.

Developed in M2PI

Close layer
prev next